Export 7 results:
Filters: Keyword is *Blood Component Transfusion/ae [Adverse Effects] [Clear All Filters]
Posttransfusion purpura occurrence and potential risk factors among the inpatient US elderly, as recorded in large Medicare databases during 2011 through 2012. Transfusion//Transfusion. 2015;55(2):284-95.
Antibody against immunoglobulin E contained in blood components as causative factor for anaphylactic transfusion reactions. Transfusion//Transfusion. 2014;54(8):1953-60.
Bye-bye TRALI: by understanding and innovation. Blood//Blood. 2014;123(22):3374-6.
Hepatitis E virus in blood components: a prevalence and transmission study in southeast England. Lancet//Lancet. 2014;384(9956):1766-73.
HBV transmission from an occult carrier with five mutations in the major hydrophilic region of HBsAg to an immunosuppressed plasma recipient. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology// J Clin Virol. 2013;58(1):315-7.
Infectivity of occult hepatitis B from two different points of view. Transfusion// Transfusion. 2013;53(7):1379-81.
Risks of hemolysis due to anti-A and anti-B caused by the transfusion of blood or blood components containing ABO-incompatible plasma. Transfusion. 2013;53 Suppl 1:114S-123S.